United Therapeutics (UTHR) Interest Expenses (2009 - 2026)
United Therapeutics (UTHR) posted Interest Expenses of $1.8 billion for Q1 2026, up 61141.38% sequentially from -$2.9 million in Q4 2025, and up 104.29% YoY from $866.5 million in Q1 2025.
United Therapeutics (UTHR) Interest Expenses (2009 - 2026) Analysis & Trends
United Therapeutics has reported Interest Expenses for 18 years, with the latest figure at $1.8 billion in Q1 2026.
- Quarterly Interest Expenses rose 104.29% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 104.29% YoY) and the FY2025 annual result came in at $19.5 million, down 54.55% from the prior year.
- Interest Expenses advanced to $1.8 billion in Q1 2026 per UTHR's latest filing, from -$2.9 million in the prior quarter.
- Over five years, Interest Expenses peaked at $1.8 billion in Q1 2026 and troughed at -$2.9 million in Q4 2025.
- A 5-year average of $646.7 million and a median of $576.5 million in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses surged 210.64% in 2022, then sank 155.77% in 2025.
- Over 5 years, Interest Expenses stood at $14.6 million in 2022, then increased by 19.86% to $17.5 million in 2023, then sank by 70.29% to $5.2 million in 2024, then plunged by 155.77% to -$2.9 million in 2025, then surged by 61141.38% to $1.8 billion in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $1.8 billion, -$2.9 million, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | 25.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Bn |
| Jun 30, 2026 | 1.18 Bn |
| Mar 31, 2026 | 1.77 Bn |
| Mar 31, 2026 | 1.77 Bn |
| Dec 31, 2025 | -2.90 Mn |
| Dec 31, 2025 | -2.90 Mn |
| Sep 30, 2025 | 1.39 Bn |
| Sep 30, 2025 | 1.39 Bn |
| Jun 30, 2025 | 730.90 Mn |
| Jun 30, 2025 | 730.90 Mn |
| Mar 31, 2025 | 866.50 Mn |
| Mar 31, 2025 | 866.50 Mn |
| Dec 31, 2024 | 5.20 Mn |
| Dec 31, 2024 | 5.20 Mn |
| Sep 30, 2024 | 1.22 Bn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.04 Bn |
| Jun 30, 2024 | 1.04 Bn |
| Mar 31, 2024 | 545.90 Mn |
| Mar 31, 2024 | 545.90 Mn |